TAG: "Eye care"

UC Davis, Orbis partner in telemedicine initiative

Alliance will work to treat, prevent blindness in the developing world.

Today, UC Davis Health System and Orbis International, a leading global non-governmental organization (NGO) that works to eliminate avoidable blindness, signed an agreement of cooperation that will expand the use of telemedicine technology to help treat and prevent blindness in the developing world.

The new alliance, which features the expertise of the UC Davis Center for Health and Technology and the UC Davis Eye Center, paves the way for developing new research, education and telehealth collaborations to advance vision science and eye care on a global scale.

The World Health Organization estimates that 285 million people are visually impaired worldwide. This includes 39 million individuals who are blind and 246 million who have low vision. About 90 percent of the world’s visually impaired live in developing countries, and 80 percent of all cases of visual impairment can be avoided or cured. These include refractive errors, cataracts and glaucoma, the leading causes of visual impairment worldwide.

Through the agreement, UC Davis specialists in telemedicine, information technology, ophthalmology, anesthesiology and nursing will work with Orbis on initiatives such as  staff development, fellowships and programs on the Orbis Flying Eye Hospital — a fully equipped mobile teaching hospital on board a DC-10 jet. Trainees will have opportunities for hands-on training in the UC Davis Center for Health and Technology simulation center and Orbis’s telehealth program for real-time surgical demonstrations.

“Orbis is honored to join in this agreement with the UC Davis Eye Center,” said Jenny Hourihan, president and chief executive officer of Orbis. “UC Davis is such an impressive partner and dedicated in helping to make quality eye health accessible while advancing programs and technology used in eye health worldwide. We are excited to collaborate and share tools and resources to expand the reach and influence that telehealth has in preventing and treating avoidable blindness.”

The project includes establishing telehealth links that will transmit live broadcasts of eye surgeries at UC Davis to virtual classrooms in remote regions in the developing world with the opportunity for trainees thousands of miles away to ask questions of surgeons in real time. It also will explore live e-consultations with partners around the world and further Orbis’s ongoing efforts to establish an open-source ophthalmic electronic medical record system, which will help develop a more robust e-health infrastructure, provide access to increased decision-making support and offer researchers a wealth of global data.

“Advances in telecommunications technologies and broadband capacity in developing countries has created new opportunities to improve training for physicians, nurses and other members of the health care team and expanded access to health care services among the world’s most vulnerable populations,” said Thomas Nesbitt, associate vice chancellor for strategic technologies and alliances at UC Davis. “By partnering with Orbis, a recognized pioneer in establishing sustainable, quality eye health care worldwide, we are leveraging UC Davis’ expertise in telehealth and distance learning to have a profound impact on global health.”

Orbis works to bring quality eye care to communities by building capacity with local partners to develop infrastructure, trained staff and, ultimately, sustainable eye care services. Since 1982, Orbis has carried out programs in 92 countries, enhanced the skills of more than 325,000 eye care professionals, and provided medical and optical treatments to more than 23.3 million adults and children. Since 2006, nearly 20 UC Davis faculty and staff have participated in 14 medical missions, traveling to China, Vietnam, Peru, Indonesia, India, El Salvador, Ethiopia, Zambia and Panama.

View original article

CATEGORY: NewsComments Off

Saving diabetics from blindness in Libya

UC Berkeley grad student, professor, alum join forces in international public service project.

UC Berkeley optometry student Fatima Elkabti and professor Jorge Cuadros discuss a magnified digital image of a healthy retina.

A UC Berkeley graduate student in optometry, one of her professors and a Berkeley alumnus have joined forces to build a long-distance diagnostic project that has the potential to keep a large number of people in crisis-torn Libya from going blind.

The public service project involves training Libyan doctors to take detailed digital photographs inside patients’ eyes, of their retinas, as part of routine health care and put the images online for remote diagnosis of damage caused by diabetes before it’s too late. Too often, diabetes-related retinopathy isn’t caught until it causes symptoms, when treatment can no longer save vision.

The first 11 Libyan doctors underwent training for three days in February in Istanbul, in a seminar organized by the Avicenna Group and taught by Berkeley optometry professor Jorge Cuadros. Turkey was chosen as the training site for security reasons and because it is easily accessible from Libya.

If all goes according to plan, many more doctors will be trained over the next year, both in Libya and out — all because of a project that developed rapidly from a seed planted in a Diabetic Health Clinic class in Berkeley’s School of Optometry.

In the class, Cuadros taught students how to analyze photos of diabetic retinopathy as part of EyePACS, the California-based online initiative he co-founded to train people working in diabetes care to screen patients’ vision for remote diagnosis by certified eye doctors.

In his class was third-year optometry student Fatima Elkabti, who knows firsthand the toll that diabetes is taking in Libya, where the disease is rampant but greatly underdiagnosed. Elkabti’s father, a Libyan, has diabetes, as do about half of her many aunts and uncles.

“I walked out of the class and asked Dr. Cuadros, ‘Can we do this in Libya?’ “ Elkabti relates. Do some research, the professor told her.

Elkabti got to work and within an hour found Ethan Chorin, who earned his Ph.D. at Berkeley in 2000, served in the U.S. diplomatic corps in Libya from 2004 to 2006 and has published a book about the recent Libyan revolution. He founded the not-for-profit Avicenna Group in 2011 with a Libyan-American colleague to catalyze health-related partnerships between Libyan organizations and U.S. universities. Traveling back and forth between Benghazi and Berkeley, he looked for ways to involve Berkeley in Libya’s reconstruction efforts.

“I shot Ethan an email, and within hours we were talking about how to make this happen,” Elkabti says. The Berkeley-Libya retinopathy project was off and running.

Diabetes-related retinopathy is one of the leading causes of blindness in Libya — as well as in the United States and in much of the world. EyePACS has brought retinal screenings to poor and medically underserved areas from California’s Central Valley to Peru, and the Libyan retinopathy project extends the concept to politically unstable and dangerous regions.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

$6.5M gift establishes UC San Diego lab for regenerative ophthalmology

New lab at Shiley Eye Center will investigate advances to reverse vision loss, blindness.

A $6.5 million gift from a grateful patient will create the Richard C. Atkinson Laboratory for Regenerative Ophthalmology in the department of ophthalmology at the UC San Diego Shiley Eye Center. The new lab will investigate cell replacement therapies, tissue engineering and other biomedical advances to reverse vision loss and blindness. Work conducted at the lab will utilize novel stem cell approaches that are consistent with the vision of the newly created Sanford Clinical Stem Cell Center at UC San Diego, which was announced in late 2013.

“This significant gift will provide UC San Diego the foundation for innovation as researchers at the Shiley Eye Center employ a multidisciplinary approach that integrates ophthalmology, vision research, bioengineering, neurosciences and stem cell biology,” said UC San Diego Chancellor Pradeep K. Khosla.

The donor chose to name the laboratory in honor of Richard Atkinson, former University of California president and UC San Diego chancellor, for his lasting impact not only on UC San Diego, but also on the entire UC system. A professor emeritus of cognitive science and psychology, Atkinson served as president of the UC system from 1995 to 2003. Before becoming president, he served for 15 years as chancellor of UC San Diego. He is a former director of the National Science Foundation.

The UC San Diego department of ophthalmology at the Shiley Eye Center is the only academic eye center in the region offering the most advanced treatments across all areas of eye care. World-class clinicians, surgeons, scientists and staff are dedicated to excellence and providing the best possible patient care to prevent, treat and cure eye diseases. The center’s research is at the forefront of developing new methods for diagnosis and treatment of eye diseases and disorders.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

The future of ophthalmology

New UC Davis facility advances the skills of eye surgeons.

Medical students and residents in the new ophthalmology training lab are able refine their surgical skills for procedures that require the use of high-powered microscopes.

The UC Davis Eye Center has opened a new state-of-the-art facility for teaching microsurgery techniques to the next generation of surgeons. Called the Lanie Albrecht Foundation Microsurgical Training Laboratory, the facility allows medical students and residents in ophthalmology and other specialties – including neurosurgery, orthopaedics, plastic surgery and veterinary medicine – to finesse their skills at performing surgeries that require the use of high-powered microscopes.

“This lab is all about enhancing the quality of patient care,” said Thomas Nesbitt, associate vice chancellor for strategic technologies and alliances at UC Davis.

“By establishing this technology-enabled learning environment, our medical residents can further refine their skills before entering the operating room.”

Funded entirely through a generous gift from the Lanie Albrecht Foundation, the new facility has seven fully equipped learning stations that ophthalmology residents can use to practice procedures such as corneal and retinal surgeries, cataract surgery and restorative oculoplastic surgery using grapes or animal eyes. Their work can be projected onto a high-resolution screen so faculty physicians can guide the process. Training sessions also can be recorded for analysis or to track milestones in each trainee’s progress.

“Practice in a controlled environment is a crucial part of becoming a skilled surgeon, and the new lab makes that possible,” said ophthalmology resident Natasha Kye.

“Residents have always gained high quality surgical training at UC Davis,” added Mark Mannis, chair of the Department of Ophthalmology. “But this wonderful new facility enables us to nurture the next generation of surgeons at a whole new level.”

View original article

CATEGORY: NewsComments Off

Venus flytraps, venom and vision

UC Irvine chemist’s offbeat interests have led to a potentially eyesight-saving discovery.

UC Irvine chemist Rachel Martin holds the eyepiece of a telescope she built. (Photo by Steve Zylius, UC Irvine)

UC Irvine chemist Rachel Martin holds the eyepiece of a telescope she built.

Rachel Martin is a thoughtful, reserved UC Irvine chemist who happens to love venom, carnivorous plants and telescopes. The last offers a clue to her latest research, which could lead to a breakthrough in treatments for epidemic blindness due to cataracts.

“I’ve been interested in optics since I was a graduate student,” she says, pulling a beautiful, hand-carved brass telescope from a box on a shelf above her desk. It’s engraved with a Leonardo da Vinci motto, “saper vedere,” which means “knowing how to see.” That was her mechanical instrumentation instructor’s motto, and she made the scope herself as a diversion from long nights earning her Ph.D. at Yale University.

Martin and her own students recently snared the December cover of the journal Structure with their trailblazing findings on how cataracts form at the molecular level. They discovered that so-called “chaperone” proteins grab onto mutant crystallin proteins in our eyes and hang on for dear life, stopping them from clumping together.

The problem is that human eyes have a finite number of these valuable chaperones. Once they’re used up, the mutant or damaged proteins begin to aggregate and cloud our vision. Now that her group has exposed the nuts and bolts of cataract creation and prevention, Martin is hopeful that organic chemists can latch onto the work and replicate the chaperone process via medicated eye solutions or artificial lenses.

“That’s the dream, and this is a big step,” says the associate professor of chemistry. “Understanding the molecular mechanism of what goes wrong in the eye that causes a cataract could lead to the development of better treatment options.”

Martin, 37, arrived at UC Irvine in 2005 to set up her own laboratory. Her husband, Carter Butts, is a UC Irvine sociology professor. A native of Phoenix, she loves California. “I like being near the ocean,” she says, “and I like the culture and the people.”

Studying cataracts was part of her job search proposal; despite her own fine eyesight, she’s keenly aware of global blindness. Nearly 20 million people worldwide have lost their sight due to cataracts. While individuals with proper medical care can have corrective surgery, the World Health Organization has found that millions in China, India, Southeast Asia, Eastern Mediterranean nations and elsewhere suffer major vision loss because they don’t have access to laser surgery or other options.

The medical potential is a powerful motivator, but Martin says it was pure chemistry – in this case a keen interest in how transparency works – that led her to investigate eye lenses. “Most things are not transparent; this is a really unusual property,” she notes.

But Martin became a chemist for different reasons. “I was absolutely fascinated by venom,” she says. “I grew up catching scorpions and centipedes and things like that.”

An “awesome” high school chemistry teacher set her on her career path, and she studies venom – as well as cataracts – to this day.

Martin is quick to praise two of her group members for working especially long hours and making major contributions to the latest findings: Carolyn Kingsley and William Brubaker. Her students also make their own precise research instruments – one of the reasons she wins praise from others.

“The remarkable thing about professor Martin’s work is that she combines the most advanced techniques in molecular biology and instrument-based chemical physics in the same lab,” says Kenneth Janda, dean of the School of Physical Sciences and a fellow chemist. “She’s remarkably broad in her talent, and her students have a unique opportunity to work in two disciplines for the same project.”

Her group is continuing the research on cataract proteins. “The next phase is to understand more about the alpha crystallin – the chaperone protein that clings onto the damaged crystallin,” Martin says.

These days, in addition to poring over data, she breeds rare plants – particularly protein-hungry ones such as Venus flytraps. With their delicate white flowers, they may be prettier than scorpions, but they share the same appetite.

View original article

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Chemists crack code of cataract creation

Findings by UC Irvine, German researchers could aid in saving sight of millions.

Cover of Structure magazineGroundbreaking new findings by UC Irvine and German chemists about how cataracts form could be used to help prevent the world’s leading cause of blindness, which currently affects nearly 20 million people worldwide.  (PDF)

“That’s the dream, and this is a big step,” said Rachel Martin, UC Irvine associate professor of chemistry and co-author of a paper featured on the December cover of the journal Structure. “Understanding the molecular mechanism of what goes wrong in the eye that leads to a cataract could lead to the development of better treatment options, including more sophisticated artificial lenses and drugs.”

It has long been known that human eyes have a powerful ability to focus because of three kinds of crystallin proteins in their lenses, maintaining transparency via a delicate balance of both repelling and attracting light. Two types of crystallin are structural, but the third – dubbed a “chaperone” – keeps the others from clumping into cataracts if they’re modified by genetic mutation, ultraviolet light or chemical damage.

The UC Irvine team painstakingly explored and identified the structures of the normal proteins and a genetic mutation known to cause cataracts in young children. They found that the chaperone proteins bind far more strongly to the mutated proteins in an effort to keep the lens clear. One major problem: Every human eye contains a finite number of the helpful proteins. Once they’re used up, the researchers learned, weakened ones quickly begin to aggregate and form blinding cataracts.

Now that this mechanism has been mapped at the molecular level, the team is hopeful that organic chemists can create sight-saving treatments to prevent such aggregation.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Donor age not a factor in most corneal transplants

Study shows “most corneal transplants have remarkable longevity regardless of donor age.”

The cornea is the clear window that allows light into the eye and helps focus it. Scarring, swelling or other damage to the cornea can lead to blurred vision. Such damage can occur after injuries or infections, from inherited conditions, or as a complication of cataract surgery.

The cornea is the clear window that allows light into the eye and helps focus it. Scarring, swelling or other damage to the cornea can lead to blurred vision. Such damage can occur after injuries or infections, from inherited conditions, or as a complication of cataract surgery.

Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, and corneas from donors over 71 perform slightly less well but still remain healthy for most transplant recipients, according to a study funded by the National Eye Institute (NEI) and led by the UC Davis Health System Eye Center and the University of Cincinnati Eye Institute.

The results were published online in Ophthalmology on Nov. 15, and presented on the same day in New Orleans at a joint meeting of the Eye Bank Association of America and the Cornea Society.

The Cornea Donor Study found that 10-year success rates remained steady at 75 percent for corneal transplants from donors 34 to 71 years old. It also found slightly higher success rates for donors under 34, and somewhat lower rates for donors over 71.

In the U.S., three-fourths of cornea donors are within the 34 to 71 age range, with one-third of donors at the upper end of the range, from 61 to 70 years old. When the study began in 2000, many surgeons would not accept corneas from donors over 65.

“The findings clearly demonstrate that most corneal transplants have remarkable longevity regardless of donor age,” said Mark Mannis, chair of ophthalmology and vision sciences, director of UC Davis Health System’s Eye Center and co-chair of the study. “The majority of patients continued to do well after 10 years, even those who received corneas from the oldest donors.”

The Corneal Donor Study  “supports continued expansion of the corneal donor pool beyond age 65,” said study co-chair Edward J. Holland, professor of ophthalmology at the University of Cincinnati and director of the Cornea Service at the Cincinnati Eye Institute.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Free health care clinic

UCLA health care staff help treat thousands at Care Harbor clinic.

A team of more than 200 UCLA health professionals helped staff a free health care clinic last week that provided vital basic medical services to approximately 3,000 uninsured and underserved people in Los Angeles.

They were among the nearly 3,000 medical and general volunteers at Care Harbor’s annual urban health clinic — held Oct. 31 through Nov. 3 at the Los Angeles Sports Arena just south of downtown Los Angeles — who provided more than 5,700 medical, dental and vision exams.

“To me it’s part of the mission of being a physician to care for people,” said Dr. Colin McCannel, a UCLA ophthalmologist. ” It’s part of what I should be doing so doing it makes me feel like I’m doing what I’m supposed to.”

There were 16 volunteers from UCLA Jules Stein Eye Institute, who conducted eye exams, donated 10 free cataract surgeries and prescribed free eye glasses. UCLA’s team also included seven doctors from family medicine, 17 general internists, and one physician from internal medicine/pediatrics, as well as some specialists and medical students.

The Care Harbor clinic provides a wide range of services for people who lack the means to get medical care on a regular basis. The health professionals screened for diabetes and hypertension, administered immunizations, offered mental health counseling and provided teeth cleanings, among many other basic services. For those patients who had more severe problems or conditions that required longer term care, the volunteers provided referrals to followup services.

The UCLA School of Dentistry staffed 10 dental chairs providing oral hygiene services for hundreds of patients.

“Service is part of the core missions and I want to take every opportunity I can to give back,” said Dr. Edmond Hewlett, a professor in the school of dentistry.

In addition to the doctors, UCLA volunteers included nearly 80 nurses from Ronald Reagan UCLA and Santa Monica medical centers; six clinical lab scientists and a pathologist from the department of pathology who interpreted the pap smears; and six nurse practitioners.

View original article

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

NIH awards $1.7M to neuroscientist for visual perception research

Work by UC Riverside professor holds promise of new therapies for people with low vision.

Aaron Seitz, UC Riverside

Aaron Seitz, UC Riverside

A UC Riverside neuroscientist has been awarded a five-year, $1.7 million grant by the National Institutes of Health to continue groundbreaking research that may lead to new therapies for individuals with amblyopia (lazy eye), dry macular degeneration and cataracts.

Research by Aaron Seitz, associate professor of psychology, already is influencing what scientists know about perceptual learning as it relates to low vision. Perceptual learning – a field of research that emerged about 30 years ago – is important to understanding brain processes, mechanisms of learning, the development of training techniques for tasks requiring specialized sensory skills, and the development of clinical applications to rehabilitate patients with sensory deficits.

His NIH research grant, “Integrating Perceptual Learning Approaches into Effective Therapies for Low Vision,” will support further study of how different mechanisms of perceptual learning interact, and will explore better treatment options for individuals with visual defects. This integrated approach into understanding brain plasticity — how the brain changes physically, chemically and functionally due to aging, injury or disease — and perceptual learning so far has been lacking in neuroscience research.

“Science research typically examines isolated processes,” he said. “Taking a broader, integrated view requires totally different tools. We need to develop a new model that combines multiple processes or mechanisms for perceptual learning. With this grant I hope we will better understand how these mechanisms can be tuned to train the brain to be more effective.”

Earlier research by Seitz challenged the popular assumption that adults learn only by paying attention to something. He found that pairing a visual stimulus with a reward is enough to cause learning, even when an individual is unaware of the stimulus paired with the reward.

“I’m truly excited about this research,” said Seitz, who joined the UCR faculty in 2008. “The science is fascinating and has tremendous potential to help people.”

Working with Dr. Stacy Pineles at the Jules Stein Eye Institute at UCLA, Dr. Pinakin Davey at the College of Optometry at Western University College of Health Sciences in Pomona and Peggy Seriès at the Institute for Adaptive and Neural Computation at University of Edinburgh, Seitz hopes to develop new therapies involving brain training to improve vision of individuals with amblyopia (lazy eye), dry macular degeneration and cataracts.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

$6.4M grant funds glaucoma study in African Americans

Study focuses on genetics of the disease in people of African descent.



A study led by Robert N. Weinreb, chairman and Distinguished Professor of Ophthalmology at the UC San Diego School of Medicine, has received a $6.4 million, 5-year grant from the National Eye Institute, part of the National Institutes of Health, to elucidate the genetics of glaucoma in persons of African descent.

Glaucoma is the leading cause of blindness in African Americans. It is four to five times more likely to occur in persons of African descent, and up to 15 times more likely to cause meaningful visual impairment in this group compared to those of European descent.

The overall goal of the study, “ADAGES III: contribution of genotype to glaucoma phenotype in African-Americans,” is to identify glaucoma genes in this high-risk, minority population, particularly persons who have rapidly worsening vision. Weinreb has teamed with Jerry Rotter, M.D., Distinguished Professor of Pediatrics, Medicine and Human Genetics at Harbor-UCLA Medical Center, a renowned genetics expert, to identify relevant genes, develop predictive models for glaucoma diagnosis and progression and discover new drug targets for therapies to reduce the visual impact of glaucoma blindness.

Glaucoma results in vision loss due to damage to the optic nerve, which is irreversible if undetected or untreated.  The most common form of glaucoma is called primary open angle glaucoma (POAG). The number of persons with diagnosed POAG in the United States is expected to be more 3.3 million by 2020, with millions more undiagnosed.  While glaucoma affects all races, persons of African descent are disproportionately affected.

“The lack of understanding about the cause of this disease impedes our ability to identify and treat it early in its development,” said Weinreb, who is also director of the Shiley Eye Center, part of the UC San Diego Health System. “Evidence of genetic contribution in the pathogenesis of POAG is well established. Since POAG tends to run in families, it is critical to identify the genetic basis of the disease in order to develop effective therapies for early intervention.”

Read more

CATEGORY: NewsComments Off

New UC Berkeley eye clinic to target youth

Rise in nearsightedness attributed partly to overuse of handheld electronics.

oo much time spent with handheld electronics could increase the risk of nearsightedness especially among children.

Too much time spent with handheld electronics could increase the risk of nearsightedness especially among children.

Eye doctors at the University of California, Berkeley, are opening a new clinic to help combat an alarming rise in myopia, or nearsightedness, which they attribute partly to the overuse of handheld electronics.

“There are a number of factors involved in the increase of myopia, but I have no doubt that changes in lifestyle over the past several decades that include more time spent indoors and the early use of handheld computers play a big role,” said Dr. Maria Liu, head of the new Myopia Control Clinic at UC Berkeley’s School of Optometry. “The problem with smartphones and iPads is that kids often hold them closer to their eyes than they would a book, and they can become totally absorbed for hours at a time. The working distance for handheld devices is much closer than it is for laptops and TV.”

Liu noted that young children are particularly vulnerable because their eyes are still developing. She added that, in particular, nearsighted children under 10 could benefit most from early intervention.

Admittedly, the overuse of handheld electronics by young children is not the only culprit for the rise in myopia. It may be that myopia is simply a byproduct of modern, urban life, said the researchers, who noted that nearsightedness rates are relatively low in agricultural regions and nations. High rates of myopia among children in East Asian countries have been attributed to long hours spent reading indoors.

A study funded by the National Eye Institute, or NEI, found that the prevalence of myopia increased 66 percent for those aged 12 to 54 years in the United States between 1971-1972 and 1999-2004.

Notably, NEI data shows that severe myopia was twice as prevalent among younger adults as for the elderly. For those aged 20 to 39, 7.4 percent had severe myopia compared with 3.1 percent for those 60 and older.

The goal of UC Berkeley’s new Myopia Control Clinic, which will operate Thursdays and Sundays, is to slow down the progression of myopia while it is still in its early phase of development. In addition to providing conventional glasses to correct myopia, doctors will be offering treatments for controlling the condition’s progression, ranging from special contact lenses to prescription eye drops.

“The early onset of myopia can have effects beyond corrective lenses,” said Liu. “The earlier the myopia starts, the longer the disorder has to develop into something more severe. It’s relatively rare, but in pathological myopia, the excessive elongation of the eyeball dramatically increases the risk for retinal detachment, growth of abnormal blood vessels and other complications, which can lead to irreversible vision loss.”

Patients can get more information or schedule appointments at the myopia clinic by calling (510) 642-2020, or by sending an email to myopiacontrol@gmail.com.

Read more

CATEGORY: NewsComments Off

A vision realized

New home of UC Irvine’s Gavin Herbert Eye Institute has been years in the making.

The Gavin Herbert Eye Institute “offers patients from both the local community and around the world access to clinically advanced eye care from internationally renowned ophthalmologists in a thoughtfully planned physical environment,” says UC Irvine Chancellor Michael Drake. (Photo by Steve Zylius, UC Irvine)

The Gavin Herbert Eye Institute “offers patients from both the local community and around the world access to clinically advanced eye care from internationally renowned ophthalmologists in a thoughtfully planned physical environment,” says UC Irvine Chancellor Michael Drake.

When the Gavin Herbert Eye Institute opens its new 70,000-square-foot home on the UC Irvine campus in September, the community will gain access to a leading-edge center for the preservation of sight, with services ranging from eyeglass fittings to refractive surgeries to clinical trials of new therapies.

The comprehensive eye health institute, which is part of UC Irvine Health, includes 34 patient exam rooms with the latest in optical equipment, an optical shop, faculty offices and conference space. A dedicated pediatric area has play areas, video entertainment screens, kid-friendly restrooms and other features to make the experience more comfortable for the youngest patients, many with special needs. The interior design reflects recommendations from the Braille Institute that make it easier for low-vision patients to navigate around the building.

“This institute offers patients from both the local community and around the world access to clinically advanced eye care from internationally renowned ophthalmologists in a thoughtfully planned physical environment,” says UC Irvine Chancellor Michael Drake. “The Gavin Herbert Eye Institute is strategically located within walking distance of two major biomedical research centers and at the epicenter of the largest concentration of eye technology companies in the world. It’s well positioned to pursue its ambitious research goal of ending blindness by 2020.”

Ten Gavin Herbert Eye Institute physicians grace Best Doctors Inc.’s list of “Best Doctors in America,” including the institute’s founding director, Dr. Roger Steinert. An internationally recognized authority on cataract, cornea and refractive surgery, he is UC Irvine’s Irving H. Leopold Chair in Ophthalmology and a professor of both ophthalmology and biomedical engineering.

“I am fortunate to lead a talented team of 24 clinicians and researchers who are dedicated to making life better for people with vision issues,” Steinert says. “The Gavin Herbert Eye Institute has attracted the best and the brightest – ophthalmologists who are eager to be part of an institute that works at the edge of science, collaborating with medical peers and eye industry professionals to develop innovative technologies and clinical practices that improve sight. It’s rewarding to be able to see our patients from the local community and around the globe benefit from these advances.”

Gavin Herbert Eye Institute physicians are known for pioneering such medical procedures as refractive and corneal transplant surgery performed with femtosecond lasers and next-generation medical therapies for age-related macular degeneration. Research teams are investigating such advanced treatments as stem cell therapies to preserve and restore sight for individuals with retinitis pigmentosa and macular degeneration; infused contact lenses that replace eye drops to treat cystinosis; and a vaccine for ocular herpes, a leading cause of blindness.

The $39 million building is the first on the UC Irvine campus to be funded entirely through local corporate, foundation and individual philanthropic gifts; no government funding was required.

James V. “Jim” Mazzo, an operating partner with Newport Beach-based Versant Ventures and a UC Irvine Foundation trustee, led the very successful community campaign. The initial naming gift came in 2007 from Gavin Herbert, founder and chairman emeritus of Allergan Inc.; his wife, Ninetta; and his mother, Josephine Herbert Gleis.

Read more

CATEGORY: SpotlightComments Off